These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7110143)

  • 41. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
    Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
    Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
    Löwy I; Leclerc C; Chedid L
    Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Covalent linkage of the synthetic adjuvant MDP to the synthetic polypeptide (T,G)-A-L changes the specificity of the immune response at the T and B cell level.
    Abehsira-Amar O; Uzan M; Audibert F; Jolivet M; Chedid L; Theze J
    Mol Immunol; 1987 Sep; 24(9):945-51. PubMed ID: 3498888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).
    Richerson HB; Suelzer MT; Swanson PA; Butler JE; Kopp WC; Rose EF
    Am J Pathol; 1982 Mar; 106(3):409-20. PubMed ID: 6101249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
    Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
    Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
    Ishihara C; Yamamoto K; Hamada N; Azuma I
    Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
    Fraser-Smith EB; Matthews TR
    Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Artificial peptide and carbohydrate antigens. Immobilization of haptens and adjuvant (MDP) on polyacrylamide].
    Iurovskiĭ VV; Bovin NV; Safonova NG; Vasilov RG; Khorlin AIa
    Bioorg Khim; 1986 Jan; 12(1):100-5. PubMed ID: 2418842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marked enhancement of macrophage activation induced by synthetic muramyl dipeptide (MDP) conjugate using monoclonal anti-MDP antibodies.
    Leclerc C; Bahr GM; Chedid L
    Cell Immunol; 1984 Jul; 86(2):269-77. PubMed ID: 6733783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity.
    Hamaoka T; Takai Y; Kosugi A; Mizushima Y; Shima J; Kusama T; Fujiwara H
    Cancer Immunol Immunother; 1985; 20(3):183-8. PubMed ID: 2933141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A shortened synthesis of adjuvant dipeptide (MDP).
    Schwartzman SM; Ribi E
    Prep Biochem; 1980; 10(3):255-67. PubMed ID: 7413603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides.
    Bahr GM; Chedid LA; Behbehani K
    Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
    Akasaki M; Takashi T; Kita Y; Tsukada W
    Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
    Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
    Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The adjuvant effect of synthetic glycopeptides on humoral immune response to thymus-dependent antigen].
    Kalina NG; Elkina SI; Moshiashvili IIa; Sergeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):97-100. PubMed ID: 6613423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
    Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
    Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic fever.
    Bahr GM; Majeed HA; Yousof AM; Chedid L; Behbehani K
    J Infect Dis; 1986 Dec; 154(6):1012-7. PubMed ID: 3782865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
    Fast DJ; Vosika GJ
    Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection.
    Yapo A; Petit JF; Lederer E; Parant M; Parant F; Chedid L
    Int J Immunopharmacol; 1982; 4(3):143-9. PubMed ID: 7049971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.